Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases

BACKGROUND: Radiation therapy with radium-223 dichloride improves overall survival, reduces symptomatic skeletal events in Caucasian patients with castration-resistant prostate cancer (CRPC) and bone metastases, and is well tolerated. We report here the results of the first efficacy and safety study...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hiroji, Uemura, Hirotsugu, Matsubara, Nobuaki, Kinuya, Seigo, Hosono, Makoto, Yajima, Yoko, Doi, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608784/
https://www.ncbi.nlm.nih.gov/pubmed/28478485
http://dx.doi.org/10.1007/s10147-017-1130-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608784/
https://www.ncbi.nlm.nih.gov/pubmed/28478485
http://dx.doi.org/10.1007/s10147-017-1130-1

Ejemplares similares